Predicted to enable biliverdin reductase (NAD(P)+) activity. Predicted to be involved in heme catabolic process. Predicted to be located in cytosol. Orthologous to human BLVRA (biliverdin reductase A). [provided by Alliance of Genome Resources, Apr 2022]